| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.23 | 0.1 |